Nonclinical safety pharmacology studies for IND and regulatory filings
This workshop will provide an integrated overview of how safety pharmacology studies support IND‑enabling development, with a focus on regulatory expectations, evolving scientific practices, and translational decision‑making. Topics will begin with an overview of current regulatory guidance and agency expectations for safety pharmacology programs, setting the framework for study scope, timing, and interpretation. Core systems..